Back
Reshape Lifesciences Stock Price Chart

7 Stocks to Consider Immediately (must-see chart)
See the green days for 7 major stocks right here, free of charge
Sell
24
RSLS
Reshape Lifesciences
Last Price:
$2.46
Seasonality Move:
-30.46%
7 Day Trial
ALL ACCESS PASS
$
7

ALERT: Q3 Could Be a Pivotal Quarter for Nasdaq Stocks
Click Here to Download Your FREE Stock Report Now-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RSLS is experiencing slight buying pressure.
Reshape Lifesciences Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.45 | Buy |
20-day SMA: | 2.53 | Sell |
50-day SMA: | 4.89 | Sell |
200-day SMA: | 68.76 | Sell |
8-day EMA: | 2.49 | Buy |
20-day EMA: | 2.9 | Sell |
50-day EMA: | 6.92 | Sell |
200-day EMA: | 196.46 | Sell |
Reshape Lifesciences Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.74 | Sell |
Relative Strength Index (14 RSI): | 38.68 | Sell |
Chaikin Money Flow: | 0 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.92 - 3.94) | Sell |
Bollinger Bands (100): | (0.89 - 23.15) | Sell |
Reshape Lifesciences Technical Analysis
Jun 25 | Jun 26 | Jun 27 | Jun 30 | Jul 1 | Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
25 | 26 | 27 | 30 | 01 | 02 | 03 | 07 | 08 | 09 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Reshape Lifesciences Stock
Is Reshape Lifesciences Stock a Buy?
-
Reshape Lifesciences share price is 2.50 while RSLS 8-day simple moving average is 2.45, which is a Buy signal.
-
The stock price of RSLS is 2.50 while Reshape Lifesciences 20-day SMA is 2.53, which makes it a Sell.
-
Reshape Lifesciences 50-day simple moving average is 4.89 while RSLS share price is 2.50, making it a Sell technically.
-
RSLS stock price is 2.50 and Reshape Lifesciences 200-day simple moving average is 68.76, creating a Sell signal.
RSLS Technical Analysis vs Fundamental Analysis
Sell
24
Reshape Lifesciences (RSLS)
is a Sell
Is Reshape Lifesciences a Buy or a Sell?
-
Reshape Lifesciences stock is rated a SellThe current Reshape Lifesciences [RSLS] share price is $2.50. The Score for RSLS is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.
Reshape Lifesciences Stock Info
Market Cap:
1.8M
Price in USD:
2.50
Share Volume:
150.4K
Reshape Lifesciences 52-Week Range
52-Week High:
347.86
52-Week Low:
2.23
Sell
24
Reshape Lifesciences (RSLS)
is a Sell
Reshape Lifesciences Share Price Forecast
-
What is the Reshape Lifesciences stock price today?The Reshape Lifesciences stock price is 2.50 USD today.
-
Will RSLS stock go up or go down?Reshape Lifesciences> share price is forecast to RISE/FALL based on technical indicators
-
Is Reshape Lifesciences overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Reshape Lifesciences is overvalued.
Is Reshape Lifesciences Stock a Buy?
-
Reshape Lifesciences share price is 2.50 while RSLS 8-day exponential moving average is 2.49, which is a Buy signal.
-
The stock price of RSLS is 2.50 while Reshape Lifesciences 20-day EMA is 2.90, which makes it a Sell.
-
Reshape Lifesciences 50-day exponential moving average is 6.92 while RSLS share price is 2.50, making it a Sell technically.
-
RSLS stock price is 2.50 and Reshape Lifesciences 200-day simple moving average is 196.46, creating a Sell signal.
Fundamental Analysis of Reshape Lifesciences
Is Reshape Lifesciences a good investment?
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.09 per share, and a decrease next year of $0.00 per share.
Technical Analysis of Reshape Lifesciences
Should I short Reshape Lifesciences stock?
-
RSLS Moving Average Covergence Divergence (MACD) indicator is -0.74, suggesting Reshape Lifesciences is a Sell
-
Reshape Lifesciences Relative Strength Index (RSI) is 38.68, which suggest Reshape Lifesciences is oversold
-
The Bollinger Bands (25) for Reshape Lifesciences is (1.92 - 3.94), which suggest Reshape Lifesciences is a Sell
-
The Bollinger Bands (100) for Reshape Lifesciences is (0.89 - 23.15), which suggest Reshape Lifesciences is a Sell
* Reshape Lifesciences stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.